1. Late divergence of survival curves in cancer immunotherapy trials: interpretation and implications

   • Fredrik B. Thorén
   • Harald Anderson
   • Örjan Strannegård

   Opinion Paper 24 August 2013 Pages: 1547 - 1551

2. Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21^waf1/cip1

   • Wai Man Liu
   • Katherine Ann Scott
   • Angus George Dalgleish

   Original Article 04 July 2013 Pages: 1553 - 1561

   

3. Clinical-scale selection and viral transduction of human naïve and central memory CD8⁺ T cells for adoptive cell therapy of cancer patients

   • Anna Casati
   • Azam Varghaei-Nahvi
   • Alexander Scheffold

   Original Article 01 August 2013 Pages: 1563 - 1573

   

4. Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma

   • Bo Wang
   • Lian Li
   • Limin Zheng

   Original Article 03 August 2013 Pages: 1575 - 1585

   

5. Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist Pam₃CSK₄ (BLP)

   • Simone König
   • Tommy Regen
   • Heidi Hahn

   Original Article 06 August 2013 Pages: 1587 - 1597

   

6. AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial

   • Sonia A. Perez
   • Eleftheria A. Anastasopoulou
   • Constantin N. Baxevanis

   Original Article 10 August 2013 Pages: 1599 - 1608

   

7. Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis

   • Monireh Mohsenzadegan
   • Zahra Madjd
   • Ahmad Shariftabrizi

   Original Article 17 August 2013 Pages: 1609 - 1618

   

8. DEAD/H (Asp–Glu–Ala–Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells

   • Jun Koshio
   • Hiroshi Kagamu
   • Ichiei Narita

   Original Article 22 August 2013 Pages: 1619 - 1628

   

9. Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer

   • Yanjuan Zhu
   • Haibo Zhang
   • Xin Qu

   Original Article 23 August 2013 Pages: 1629 - 1635

   

10. Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1

    • Yibing Xu
    • Jianping Sun
    • Robert C. Seeger

    Original Article Open access 27 August 2013 Pages: 1637 - 1648